⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
ROSEN, A LONGSTANDING LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Contact Levi & Korsinsky to Join Class Action Before October 5, 2026
accessnewswire.com
SPRY
Robbins LLP Reminds Investors of the Securities Fraud Class Action Lawsuit Against ARS Pharmaceuticals Inc. Following a More Than 23% Stock Drop on June 25, 2026
globenewswire.com
SPRY
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY